Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Horse versus rabbit anti-thymocyte globulin with cyclosporine A in pediatric severe aplastic anaemia
ISRCTN70251363Phase 4Completed
- Sponsor
- Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology
- Start
- Dec 2000
- Modality
- Small Molecules, Peptides, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of antithymocyte globulin, antithymocyte globulin rabbit and cyclosporine in acquired aplastic anemia (AAA) (2 arms), sponsored by Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology. Primary endpoints: Minimal haematologic response rate, Complete haematologic response rate and 1 more. Started Dec 2000; status: completed.
02
Drugs
antithymocyte globulinantithymocyte globulin rabbitcyclosporine
03
Conditions
acquired aplastic anemia (AAA)
Beyond the preview
Go deeper on ISRCTN70251363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN70251363.